Condition (MeSH)
Hyperkinesis
ClinicalTrials.gov lists 9 trials for Hyperkinesis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
9 of the 9 trials are tagged with Hyperkinesis itself; the rest are tagged with a narrower condition beneath it.
When did Hyperkinesis trials start? (8)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 2
- Phase 3
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 2 |
| 2024 | 1 |
| 2022 | 1 |
| 2019 | 1 |
| 2017 | 1 |
| 2015 | 1 |
| 2008 | 1 |
| 2003 | 1 |
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Hyperkinesis trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 2 |
| Phase 2 | 1 |
| Phase 3 | 1 |
| Not applicable | 2 |
| Observational | 3 |
How many Hyperkinesis trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Completed | 6 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Hyperkinesis trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| Yaupon Therapeutics | 1 |
Which publications cover Hyperkinesis? (68)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| In vivo evaluation of effects of histamine H<sub>3</sub> receptor antagonists on methamphetamine-induced hyperlocomotion in mice. | Brain research | 2020 | Yes |
| The role of dopamine in the brain - lessons learned from Parkinson's disease. | NeuroImage | 2019 | Yes |
| Head Motion and Inattention/Hyperactivity Share Common Genetic Influences: Implications for fMRI Studies of ADHD. | PloS one | 2016 | Yes |
| Adult Brain Serotonin Deficiency Causes Hyperactivity, Circadian Disruption, and Elimination of Siestas. | The Journal of neuroscience : the official journal of the Society for Neuroscience | 2016 | Yes |
| Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder. | The American journal of psychiatry | 2015 | Yes |
Showing 5 of 68 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.